Home › Research › Topics › assessment
assessment
849 studies tagged assessment, dated 1982-05-01 to 2026-09-16. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Feasibility of remote self-administered cognitive assessment in an Alzheimer's disease treatment clinic 2026-09-16
- Structural brain imaging for newly diagnosed cognitive impairment by Medicare coverage type 2026-09-15
- Detection and Continuous Monitoring of Memory Dysfunction in Mild Cognitive Impairment and Healthy Aging Through Adaptive Computational Phenotyping 2026-09-12
Studies
849 studies carry this tag.
Date range
1982 to 2026
Top journals
- Neurology 63
- Journal of Alzheimer's disease : JAD 31
- Archives of neurology 30
- Alzheimer s & Dementia 25
- Alzheimer's & dementia : the journal of the Alzheimer's Association 21
316 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Most factors of the MoCA-B were significantly different between the two groups, and the PSCN group completed the MoCA-B faster (p 0.05).
-
BackgroundPatients with dementia face driving difficulties and, at some point, cease driving.
-
is a heuristic that seeks to develop methodologies capable of identifying subtle behavior(s) that may flag emerging AD and other dementia related syndromes.
-
The 3D-CAM-S severity scores correlated with DRS, delirium duration, and biomarkers of delirium.
-
56/100
ADNI participants (921 dyads) had a mean (SD) age of 71 (7) years and mean (SD) of 17 (3) years of education; 485 (53%) were female, 30 (3%) were Asian, 105 (11%) were Black, and 756 (82%) were White. eVAL participants (279 dyads) had a mean (SD) age of 71 (8) years and mean (SD) of 17 (2) years of education; 151 (54%) were female, 17 (6%) were Asian, 12 (4%) were Black, and 245 (88%) were White.
-
Mild Cognitive Impairment (MCI) is a transitional stage between normal age-related cognitive decline and the more severe cognitive loss seen in dementia.
-
BackgroundAccurate classification of cognitive impairment in population studies is challenging.
-
Our findings support apathy and APOE ε4 as robust predictors of conversion to MCI and ADD, and demonstrate novel associations between antidepressant use and conversion.
-
To date, the impact of cognitive therapies on patients with dementia and mild cognitive impairment (MCI) has been studied in terms of cognition, quality of life and activities of daily living rather than in the context of neuropsychiatric symptoms (NPS).
-
39/100
At baseline, the mean ZBI score was 24.5 ± 15.2 and correlated positively with caregiver CES-D and STAI scores and with patient neuropsychiatric symptoms (NPI-frequency × severity) and distress felt by the caregiver (NPI-distress).
-
90%) rated the app favorably, stating it was enjoyable and easy to complete unsupervised.
-
For the interim analysis as of October 2024, the results of the MCI study arm are reported (n=42).
-
This innovative study aims to test the feasibility of iTBS as a cognitive enhancement strategy in MCI.
-
Though biomarker assessments showed significant Aβ reduction for both anti-amyloid therapies, no direct correlation with clinical outcomes was observed, limiting their use as surrogate endpoints.
-
BackgroundCognitive impairment is common in older adults and negatively affects hearing aid use.
-
Of 44,899 MCI patients, 6391 progressed to AD.
-
The three cognitive assessment tools were valid for detecting subjects with MCI or dementia according to ROC analysis.
-
49/100
Of 164,508 eligible participants, 6605(4%) had cognitive testing scores consistent with MCI.
-
MEG 16-38Hz spectral power, particularly over parieto-occipital magnetometers, was significantly reduced in the AD progression group.
-
> 0.05). We observed distinct cognitive performances in subjects from both the DLB and AD groups across different stages of dementia.
-
BackgroundStructural changes in medial temporal lobes including the fusiform gyrus, a critical area in face recognition, precede the progression of amnestic mild cognitive impairment (aMCI) to Alzheimer's disease (AD).
-
Overall, the combined features model achieved a higher discrimination accuracy than models with single feature sets alone.
-
The results showed that Age, Education, and, occasionally, Biological sex were significant predictors.
-
Our results showed that: (a) Behavioral data analysis: there were significant differences in accuracy and accuracy / reaction time between MCI and NC in tasks with memory load capacity of low load-four and high load-six, especially in tasks with memory load capacity of four.
-
The tests qualitatively and statistically associated to a cognitive decline are MMSE, FAB, BSTR, AM, and VSF, of which at least three were considered the most informative also by machine learning. 73% average accuracy was obtained in the diagnosis prediction on three subsets of original and external data.
-
No model terms met the a priori cut-off beyond the base model, including device type, response input source (e.g. mouse, etc.), or session interference.
-
Mild cognitive impairment (MCI) is a clinical condition characterized by a decline in cognitive ability and progression of cognitive impairment.
-
Among our participants, aMCI and VCIND demonstrated prevalence of 14.83% and 2.71%, respectively, and annual incidence (per 1000 person-years) of 69.6 and 10.6, respectively.
-
Statistical analysis revealed a trend toward more impaired prefrontal FC with declining cognitive function.
-
Parameters such as clinical status, GCA scale, MTA scale, Fazekas scale, strategic infarction, Koedam score, stroke, hypertension, diabetes mellitus, dyslipidemia, and cardiovascular disease do not have significant correlations with MoCA-INA scores.
-
BackgroundEarly mild cognitive impairment (EMCI) represents a prodromal stage of dementia, and early detection is crucial for delaying dementia progression.
-
Early detection of abnormal neurodegeneration amidst normal cognitive aging is crucial.
-
With the top 20 acoustic features, our framework achieved classification accuracies of 62.2% (EER: 0.3335) on the FHS dataset for NC, MCI, and DE differentiation, and 63.7% (EER: 0.1796) on the DBD dataset for NC and MCI differentiation, using obfuscated speech files.
-
BackgroundIndividuals with type 2 diabetes have an increased risk of developing both vascular and Alzheimer's dementia.
-
Our findings showed the strong predictive potential of PET, particularly florbetaben (FBB), which achieved an AUC of 0.84.
-
The combination of antiretroviral therapy (cART) and preventive measures has significantly enhanced the management of Human Immunodeficiency Virus (HIV) infection.
-
Dementia rates are projected to increase significantly by 2050, posing considerable challenges for healthcare systems worldwide.
-
In amnestic mild cognitive impairment (aMCI), neuroinflammation evolves during disease progression, affecting microglial function and potentially accelerating the pathological process.
-
-values compared to gait features. Linear regression analysis indicated that turn dynamics had stronger correlations with executive function and working memory, suggesting a more pronounced relationship between cognitive performance and turn features than gait variables.
-
In patients with cognitive impairment due to diverse causes, the HTS might occur regardless of MCI versus dementia status and across different etiologies.
-
< 0.001] total scores differed significantly between groups, with controls (median MoCA 28.5, 95% CI 28.0-29.0; median MMSE 30, 95% CI 30.0-30.0) outperforming prodromal (median MoCA 26, 95% CI 23.0-27.0; median MMSE 29, 95% CI 27.5-29.5) and symptomatic (median MoCA 20.5, 95% CI 17.0-24.0; median MMSE 26, 95% CI 23.5-29.0) carriers.
-
Vision impairment is common among older adults and affects dementia screening assessments, which include visually presented items.
-
Alzheimer's disease (AD) remains a formidable challenge in modern healthcare, necessitating innovative approaches for its early detection and intervention.
-
The rate of reversion from MCI to normal cognition was 37.0% after 2 years and 32.9% after 12 years.
-
These findings suggest that visual function plays a crucial role in the cognitive and functional abilities of patients with MCI.
-
Mild Cognitive Impairment (MCI) is marked by a measurable decline in cognitive function that exceeds typical age-related changes but does not yet qualify as dementia.
-
We consider the recent publication by Ornish and colleagues and the rigor expected for interventional clinical trials.
-
NPS was longitudinally associated with performance in each cognitive domain.
-
Female gender, older age, and lower levels of education were associated with poorer overall test scores.
-
Alzheimer's disease (AD) is a complex, progressive, and irreversible neurodegenerative disorder marked by cognitive decline and memory loss.
From across this tag
9 of the 848 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.
- Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease
- The characterisation of subjective cognitive decline
- Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment
- The Validity and Reliability of the Mini-Mental State Examination-2 for Detecting Vascular Mild Cognitive Impairment and Vascular Dementia in a Korean Population
- Current epidemiology of mild cognitive impairment and other predementia syndromes
- Development and Validation of a Cutoff for the Chair Stand Test as a Screening for Mobility Impairment in the Context of the Integrated Care for Older People Program
- Cognitive Frailty: A Systematic Review of Epidemiological and Neurobiological Evidence of an Age-Related Clinical Condition
- Improving identification of cognitive impairment in primary care
- Mobile technologies in the early detection of cognitive decline